Facebook

Tuberculosis

We are calling for the development of a point-of-care TB test and working to increase access to treatment for drug resistant TB by supporting the introduction of promising new medicines and tackling supply problems of older drugs.

10. October 2017.
|
MDR-TB DRUGS

New issue brief: Four years and counting

Slow scale-up of newer MDR-TB drugs covers less than 5% in need.
This issue brief examines current opportunities to optimise MDR-TB treatment and to address the persistent access challenges that put treatment out of reach for people struggling to survive this deadly disease. Read more

Photo by Atul Loke/Panos pictures

Tuberculosis: The Issues

Cambodia © Sean Brokenshire/MSF

Learn about the issues MSF & others confront in the diagnosis and treatment of tuberculosis.

» Read more

Featured multimedia

XDR-TB patient successfully completes treatment
Late 2013, Elizabeth started treatment for multidrug-resistant tuberculosis (MDR-TB) at MSF’s Green House Clinic in Nairobi...

Tags: tuberculosis, XDR-TB, bedaquiline

↑ To top